APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dry Powder Inhaler Device

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

Selected research

Market Structure

Global Dry Powder Inhaler Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026196 pages

Choose your research edition.

Industry ResearchDry Powder Inhaler Device Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Dry Powder Inhaler Device Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Dry Powder Inhaler Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dry Powder Inhaler Device Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Dry Powder Inhaler Device Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, etc. are the key players in the global Dry Powder Inhaler Device market. Top 4 took up more than 30% of the global market.

From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%. In addition, Asia Pacific is also play important role in Global market.

Read the full market overview

Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%. Then followed by the COPD.

According to the Segmentation of types, all the market of Dry Powder Inhaler Device can be divided as follows: Multi-dose, Single-dose.

This report provides an overview of the global Dry Powder Inhaler Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dry Powder Inhaler Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dry Powder Inhaler Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dry Powder Inhaler Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Dry Powder Inhaler Device Segment by Company

GlaxoSmithKline

AstraZeneca

Boehringer Ingelheim

Chiesi

Cipla

3M

Hovione

Mannkind

Mylan

Novartis

Schering/Merck

Teva

Vectura

Dry Powder Inhaler Device Segment by Type

Single Dose

Multi Dose

Dry Powder Inhaler Device Segment by Application

Asthma

COPD

Others

Dry Powder Inhaler Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Powder Inhaler Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dry Powder Inhaler Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Powder Inhaler Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dry Powder Inhaler Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dry Powder Inhaler Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dry Powder Inhaler Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dry Powder Inhaler Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dry Powder Inhaler Device Industry Trends Table 2. Dry Powder Inhaler Device Industry Drivers Table 3. Dry Powder Inhaler Device Industry Opportunities and Challenges Table 4. Dry Powder Inhaler Device Industry Restraints Table 5. Global Dry Powder Inhaler Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dry Powder Inhaler Device Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dry Powder Inhaler Device Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Dry Powder Inhaler Device Sales Market Share by Manufacturers Table 9. Global Dry Powder Inhaler Device Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Dry Powder Inhaler Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dry Powder Inhaler Device Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dry Powder Inhaler Device Manufacturers, Product Type & Application Table 13. Global Dry Powder Inhaler Device Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dry Powder Inhaler Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Single Dose Table 17. Major Manufacturers of Multi Dose Table 18. Global Dry Powder Inhaler Device Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Dry Powder Inhaler Device Sales by Type (2021-2026) & (K Units) Table 20. Global Dry Powder Inhaler Device Sales by Type (2027-2032) & (K Units) Table 21. Global Dry Powder Inhaler Device Sales Market Share by Type (2021-2026) Table 22. Global Dry Powder Inhaler Device Sales Market Share by Type (2027-2032) Table 23. Global Dry Powder Inhaler Device Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Dry Powder Inhaler Device Revenue by Type (2021-2026) & (K Units) Table 25. Global Dry Powder Inhaler Device Revenue by Type (2027-2032) & (K Units) Table 26. Global Dry Powder Inhaler Device Revenue Market Share by Type (2021-2026) Table 27. Global Dry Powder Inhaler Device Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Asthma Table 29. Major Manufacturers of COPD Table 30. Major Manufacturers of Others Table 31. Global Dry Powder Inhaler Device Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Dry Powder Inhaler Device Sales by Application (2021-2026) & (K Units) Table 33. Global Dry Powder Inhaler Device Sales by Application (2027-2032) & (K Units) Table 34. Global Dry Powder Inhaler Device Sales Market Share by Application (2021-2026) Table 35. Global Dry Powder Inhaler Device Sales Market Share by Application (2027-2032) Table 36. Global Dry Powder Inhaler Device Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Dry Powder Inhaler Device Revenue by Application (2021-2026) & (K Units) Table 38. Global Dry Powder Inhaler Device Revenue by Application (2027-2032) & (K Units) Table 39. Global Dry Powder Inhaler Device Revenue Market Share by Application (2021-2026) Table 40. Global Dry Powder Inhaler Device Revenue Market Share by Application (2027-2032) Table 41. Global Dry Powder Inhaler Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Dry Powder Inhaler Device Sales by Region (2021-2026) & (K Units) Table 43. Global Dry Powder Inhaler Device Sales Market Share by Region (2021-2026) Table 44. Global Dry Powder Inhaler Device Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Dry Powder Inhaler Device Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Dry Powder Inhaler Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Dry Powder Inhaler Device Sales by Country (2021-2026) & (K Units) Table 48. North America Dry Powder Inhaler Device Sales by Country (2027-2032) & (K Units) Table 49. Europe Dry Powder Inhaler Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Dry Powder Inhaler Device Sales by Country (2021-2026) & (K Units) Table 51. Europe Dry Powder Inhaler Device Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Dry Powder Inhaler Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Dry Powder Inhaler Device Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Dry Powder Inhaler Device Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Dry Powder Inhaler Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Dry Powder Inhaler Device Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Dry Powder Inhaler Device Sales by Country (2027-2032) & (K Units) Table 58. Global Dry Powder Inhaler Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Dry Powder Inhaler Device Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Dry Powder Inhaler Device Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Dry Powder Inhaler Device Revenue Market Share by Region (2021-2026) Table 62. Global Dry Powder Inhaler Device Revenue Market Share by Region (2027-2032) Table 63. GlaxoSmithKline Company Information Table 64. GlaxoSmithKline Business Overview Table 65. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio Table 67. GlaxoSmithKline Recent Development Table 68. AstraZeneca Company Information Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. AstraZeneca Dry Powder Inhaler Device Product Portfolio Table 72. AstraZeneca Recent Development Table 73. Boehringer Ingelheim Company Information Table 74. Boehringer Ingelheim Business Overview Table 75. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio Table 77. Boehringer Ingelheim Recent Development Table 78. Chiesi Company Information Table 79. Chiesi Business Overview Table 80. Chiesi Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Chiesi Dry Powder Inhaler Device Product Portfolio Table 82. Chiesi Recent Development Table 83. Cipla Company Information Table 84. Cipla Business Overview Table 85. Cipla Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Cipla Dry Powder Inhaler Device Product Portfolio Table 87. Cipla Recent Development Table 88. 3M Company Information Table 89. 3M Business Overview Table 90. 3M Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. 3M Dry Powder Inhaler Device Product Portfolio Table 92. 3M Recent Development Table 93. Hovione Company Information Table 94. Hovione Business Overview Table 95. Hovione Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Hovione Dry Powder Inhaler Device Product Portfolio Table 97. Hovione Recent Development Table 98. Mannkind Company Information Table 99. Mannkind Business Overview Table 100. Mannkind Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Mannkind Dry Powder Inhaler Device Product Portfolio Table 102. Mannkind Recent Development Table 103. Mylan Company Information Table 104. Mylan Business Overview Table 105. Mylan Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Mylan Dry Powder Inhaler Device Product Portfolio Table 107. Mylan Recent Development Table 108. Novartis Company Information Table 109. Novartis Business Overview Table 110. Novartis Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Novartis Dry Powder Inhaler Device Product Portfolio Table 112. Novartis Recent Development Table 113. Schering/Merck Company Information Table 114. Schering/Merck Business Overview Table 115. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Schering/Merck Dry Powder Inhaler Device Product Portfolio Table 117. Schering/Merck Recent Development Table 118. Teva Company Information Table 119. Teva Business Overview Table 120. Teva Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Teva Dry Powder Inhaler Device Product Portfolio Table 122. Teva Recent Development Table 123. Vectura Company Information Table 124. Vectura Business Overview Table 125. Vectura Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Vectura Dry Powder Inhaler Device Product Portfolio Table 127. Vectura Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Dry Powder Inhaler Device Distributors List Table 131. Dry Powder Inhaler Device Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Dry Powder Inhaler Device Product Image Figure 2. Global Dry Powder Inhaler Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dry Powder Inhaler Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Dry Powder Inhaler Device Sales (2021-2032) & (K Units) Figure 5. Global Dry Powder Inhaler Device Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dry Powder Inhaler Device Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Single Dose Image Figure 9. Multi Dose Image Figure 10. Global Dry Powder Inhaler Device Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Dry Powder Inhaler Device Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Dry Powder Inhaler Device Sales Market Share by Type (2021-2032) Figure 13. Global Dry Powder Inhaler Device Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Dry Powder Inhaler Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Dry Powder Inhaler Device Revenue Market Share by Type (2021-2032) Figure 16. Asthma Image Figure 17. COPD Image Figure 18. Others Image Figure 19. Global Dry Powder Inhaler Device Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Dry Powder Inhaler Device Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Dry Powder Inhaler Device Sales Market Share by Application (2021-2032) Figure 22. Global Dry Powder Inhaler Device Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Dry Powder Inhaler Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Dry Powder Inhaler Device Revenue Market Share by Application (2021-2032) Figure 25. North America Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Dry Powder Inhaler Device Sales Market Share by Country (2021-2032) Figure 27. U.S. Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Dry Powder Inhaler Device Sales Market Share by Country (2021-2032) Figure 32. Germany Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Dry Powder Inhaler Device Sales Market Share by Country (2021-2032) Figure 39. China Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Country (2021-2032) Figure 47. Brazil Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Dry Powder Inhaler Device Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Dry Powder Inhaler Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Dry Powder Inhaler Device Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Dry Powder Inhaler Device Revenue (2021-2032) & (US$ Million) Figure 58. North America Dry Powder Inhaler Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Dry Powder Inhaler Device Revenue (2021-2032) & (US$ Million) Figure 60. Europe Dry Powder Inhaler Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Dry Powder Inhaler Device Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Dry Powder Inhaler Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Dry Powder Inhaler Device Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Dry Powder Inhaler Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Dry Powder Inhaler Device Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Dry Powder Inhaler Device Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Single Dose
  • Multi Dose
Applications
  • Asthma
  • COPD
  • Others
Companies covered
  • GlaxoSmithKline
  • AstraZeneca
  • Boehringer Ingelheim
  • Chiesi
  • Cipla
  • 3M
  • Hovione
  • Mannkind
  • Mylan
  • Novartis
  • Schering/Merck
  • Teva
  • Vectura

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dry Powder Inhaler Device Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dry Powder Inhaler Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dry Powder Inhaler Device Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dry Powder Inhaler Device Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dry Powder Inhaler Device Market Dynamics
  1. 2.1 Dry Powder Inhaler Device Industry Trends
  2. 2.2 Dry Powder Inhaler Device Industry Drivers
  3. 2.3 Dry Powder Inhaler Device Industry Opportunities and Challenges
  4. 2.4 Dry Powder Inhaler Device Industry Restraints
3 Dry Powder Inhaler Device Market by Manufacturers
  1. 3.1 Global Dry Powder Inhaler Device Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dry Powder Inhaler Device Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dry Powder Inhaler Device Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dry Powder Inhaler Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dry Powder Inhaler Device Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dry Powder Inhaler Device Manufacturers, Product Type & Application
  7. 3.7 Global Dry Powder Inhaler Device Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dry Powder Inhaler Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dry Powder Inhaler Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dry Powder Inhaler Device Tier 1, Tier 2, and Tier 3
4 Dry Powder Inhaler Device Market by Type
  1. 4.1 Dry Powder Inhaler Device Type Introduction
  2. 4.1.1 Single Dose
  3. 4.1.2 Multi Dose
  4. 4.2 Global Dry Powder Inhaler Device Sales by Type
  5. 4.2.1 Global Dry Powder Inhaler Device Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dry Powder Inhaler Device Sales by Type (2021-2032)
  7. 4.2.3 Global Dry Powder Inhaler Device Sales Market Share by Type (2021-2032)
  8. 4.3 Global Dry Powder Inhaler Device Revenue by Type
  9. 4.3.1 Global Dry Powder Inhaler Device Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dry Powder Inhaler Device Revenue by Type (2021-2032)
  11. 4.3.3 Global Dry Powder Inhaler Device Revenue Market Share by Type (2021-2032)
5 Dry Powder Inhaler Device Market by Application
  1. 5.1 Dry Powder Inhaler Device Application Introduction
  2. 5.1.1 Asthma
  3. 5.1.2 COPD
  4. 5.1.3 Others
  5. 5.2 Global Dry Powder Inhaler Device Sales by Application
  6. 5.2.1 Global Dry Powder Inhaler Device Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dry Powder Inhaler Device Sales by Application (2021-2032)
  8. 5.2.3 Global Dry Powder Inhaler Device Sales Market Share by Application (2021-2032)
  9. 5.3 Global Dry Powder Inhaler Device Revenue by Application
  10. 5.3.1 Global Dry Powder Inhaler Device Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dry Powder Inhaler Device Revenue by Application (2021-2032)
  12. 5.3.3 Global Dry Powder Inhaler Device Revenue Market Share by Application (2021-2032)
6 Global Dry Powder Inhaler Device Sales by Region
  1. 6.1 Global Dry Powder Inhaler Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dry Powder Inhaler Device Sales by Region (2021-2032)
  3. 6.2.1 Global Dry Powder Inhaler Device Sales by Region (2021-2026)
  4. 6.2.2 Global Dry Powder Inhaler Device Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dry Powder Inhaler Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dry Powder Inhaler Device Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dry Powder Inhaler Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dry Powder Inhaler Device Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dry Powder Inhaler Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dry Powder Inhaler Device Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dry Powder Inhaler Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dry Powder Inhaler Device Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dry Powder Inhaler Device Revenue by Region
  1. 7.1 Global Dry Powder Inhaler Device Revenue by Region
  2. 7.1.1 Global Dry Powder Inhaler Device Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dry Powder Inhaler Device Revenue by Region (2021-2026)
  4. 7.1.3 Global Dry Powder Inhaler Device Revenue by Region (2027-2032)
  5. 7.1.4 Global Dry Powder Inhaler Device Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dry Powder Inhaler Device Revenue (2021-2032)
  8. 7.2.2 North America Dry Powder Inhaler Device Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dry Powder Inhaler Device Revenue (2021-2032)
  11. 7.3.2 Europe Dry Powder Inhaler Device Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dry Powder Inhaler Device Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dry Powder Inhaler Device Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dry Powder Inhaler Device Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dry Powder Inhaler Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GlaxoSmithKline
  2. 8.1.1 GlaxoSmithKline Company Information
  3. 8.1.2 GlaxoSmithKline Business Overview
  4. 8.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
  6. 8.1.5 GlaxoSmithKline Recent Developments
  7. 8.2 AstraZeneca
  8. 8.2.1 AstraZeneca Company Information
  9. 8.2.2 AstraZeneca Business Overview
  10. 8.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AstraZeneca Dry Powder Inhaler Device Product Portfolio
  12. 8.2.5 AstraZeneca Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Chiesi
  20. 8.4.1 Chiesi Company Information
  21. 8.4.2 Chiesi Business Overview
  22. 8.4.3 Chiesi Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Chiesi Dry Powder Inhaler Device Product Portfolio
  24. 8.4.5 Chiesi Recent Developments
  25. 8.5 Cipla
  26. 8.5.1 Cipla Company Information
  27. 8.5.2 Cipla Business Overview
  28. 8.5.3 Cipla Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cipla Dry Powder Inhaler Device Product Portfolio
  30. 8.5.5 Cipla Recent Developments
  31. 8.6 3M
  32. 8.6.1 3M Company Information
  33. 8.6.2 3M Business Overview
  34. 8.6.3 3M Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 3M Dry Powder Inhaler Device Product Portfolio
  36. 8.6.5 3M Recent Developments
  37. 8.7 Hovione
  38. 8.7.1 Hovione Company Information
  39. 8.7.2 Hovione Business Overview
  40. 8.7.3 Hovione Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hovione Dry Powder Inhaler Device Product Portfolio
  42. 8.7.5 Hovione Recent Developments
  43. 8.8 Mannkind
  44. 8.8.1 Mannkind Company Information
  45. 8.8.2 Mannkind Business Overview
  46. 8.8.3 Mannkind Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mannkind Dry Powder Inhaler Device Product Portfolio
  48. 8.8.5 Mannkind Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Dry Powder Inhaler Device Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Dry Powder Inhaler Device Product Portfolio
  60. 8.10.5 Novartis Recent Developments
  61. 8.11 Schering/Merck
  62. 8.11.1 Schering/Merck Company Information
  63. 8.11.2 Schering/Merck Business Overview
  64. 8.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Schering/Merck Dry Powder Inhaler Device Product Portfolio
  66. 8.11.5 Schering/Merck Recent Developments
  67. 8.12 Teva
  68. 8.12.1 Teva Company Information
  69. 8.12.2 Teva Business Overview
  70. 8.12.3 Teva Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Teva Dry Powder Inhaler Device Product Portfolio
  72. 8.12.5 Teva Recent Developments
  73. 8.13 Vectura
  74. 8.13.1 Vectura Company Information
  75. 8.13.2 Vectura Business Overview
  76. 8.13.3 Vectura Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Vectura Dry Powder Inhaler Device Product Portfolio
  78. 8.13.5 Vectura Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dry Powder Inhaler Device Value Chain Analysis
  2. 9.1.1 Dry Powder Inhaler Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dry Powder Inhaler Device Production Mode & Process
  6. 9.2 Dry Powder Inhaler Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dry Powder Inhaler Device Distributors
  9. 9.2.3 Dry Powder Inhaler Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst